These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

473 related articles for article (PubMed ID: 32219719)

  • 1. Assessment of antifungal resistance and associated molecular mechanism in Candida albicans isolates from different cohorts of patients in North Indian state of Haryana.
    Kumar A; Nair R; Kumar M; Banerjee A; Chakrabarti A; Rudramurthy SM; Bagga R; Gaur NA; Mondal AK; Prasad R
    Folia Microbiol (Praha); 2020 Aug; 65(4):747-754. PubMed ID: 32219719
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Molecular mechanisms associated with Fluconazole resistance in clinical Candida albicans isolates from India.
    Mane A; Vidhate P; Kusro C; Waman V; Saxena V; Kulkarni-Kale U; Risbud A
    Mycoses; 2016 Feb; 59(2):93-100. PubMed ID: 26648048
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Activity of Isavuconazole and Other Azoles against Candida Clinical Isolates and Yeast Model Systems with Known Azole Resistance Mechanisms.
    Sanglard D; Coste AT
    Antimicrob Agents Chemother; 2016 Jan; 60(1):229-38. PubMed ID: 26482310
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Molecular mechanisms of drug resistance in clinical Candida species isolated from Tunisian hospitals.
    Eddouzi J; Parker JE; Vale-Silva LA; Coste A; Ischer F; Kelly S; Manai M; Sanglard D
    Antimicrob Agents Chemother; 2013 Jul; 57(7):3182-93. PubMed ID: 23629718
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Analysis of global antifungal surveillance results reveals predominance of Erg11 Y132F alteration among azole-resistant Candida parapsilosis and Candida tropicalis and country-specific isolate dissemination.
    Castanheira M; Deshpande LM; Messer SA; Rhomberg PR; Pfaller MA
    Int J Antimicrob Agents; 2020 Jan; 55(1):105799. PubMed ID: 31520783
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Analysis of CDR1 and MDR1 Gene Expression and ERG11 Substitutions in Clinical Candida tropicalis Isolates from Alexandria, Egypt.
    El-Kholy MA; Helaly GF; El Ghazzawi EF; El-Sawaf G; Shawky SM
    Braz J Microbiol; 2023 Dec; 54(4):2609-2615. PubMed ID: 37606863
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A multicentre study of antifungal susceptibility patterns among 350 Candida auris isolates (2009-17) in India: role of the ERG11 and FKS1 genes in azole and echinocandin resistance.
    Chowdhary A; Prakash A; Sharma C; Kordalewska M; Kumar A; Sarma S; Tarai B; Singh A; Upadhyaya G; Upadhyay S; Yadav P; Singh PK; Khillan V; Sachdeva N; Perlin DS; Meis JF
    J Antimicrob Chemother; 2018 Apr; 73(4):891-899. PubMed ID: 29325167
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Monitoring Antifungal Resistance in a Global Collection of Invasive Yeasts and Molds: Application of CLSI Epidemiological Cutoff Values and Whole-Genome Sequencing Analysis for Detection of Azole Resistance in Candida albicans.
    Castanheira M; Deshpande LM; Davis AP; Rhomberg PR; Pfaller MA
    Antimicrob Agents Chemother; 2017 Oct; 61(10):. PubMed ID: 28784671
    [TBL] [Abstract][Full Text] [Related]  

  • 9. ERG11 mutations and expression of resistance genes in fluconazole-resistant Candida albicans isolates.
    Xu Y; Sheng F; Zhao J; Chen L; Li C
    Arch Microbiol; 2015 Nov; 197(9):1087-93. PubMed ID: 26349561
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Reduced susceptibility of Candida albicans clinical isolates to azoles and detection of mutations in the ERG11 gene.
    Zhang L; Yang HF; Liu YY; Xu XH; Ye Y; Li JB
    Diagn Microbiol Infect Dis; 2013 Dec; 77(4):327-9. PubMed ID: 24070847
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Molecular mechanisms of azole resistance in Candida tropicalis isolates causing invasive candidiasis in China.
    Fan X; Xiao M; Zhang D; Huang JJ; Wang H; Hou X; Zhang L; Kong F; Chen SC; Tong ZH; Xu YC
    Clin Microbiol Infect; 2019 Jul; 25(7):885-891. PubMed ID: 30472420
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mutations and/or Overexpressions of ERG4 and ERG11 Genes in Clinical Azoles-Resistant Isolates of Candida albicans.
    Feng W; Yang J; Xi Z; Qiao Z; Lv Y; Wang Y; Ma Y; Wang Y; Cen W
    Microb Drug Resist; 2017 Jul; 23(5):563-570. PubMed ID: 27976986
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Resistance mechanisms in clinical isolates of Candida albicans.
    White TC; Holleman S; Dy F; Mirels LF; Stevens DA
    Antimicrob Agents Chemother; 2002 Jun; 46(6):1704-13. PubMed ID: 12019079
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Missense mutation in CgPDR1 regulator associated with azole-resistant Candida glabrata recovered from Thai oral candidiasis patients.
    Tantivitayakul P; Lapirattanakul J; Kaypetch R; Muadcheingka T
    J Glob Antimicrob Resist; 2019 Jun; 17():221-226. PubMed ID: 30658200
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Drug resistance genes and trailing growth in Candida albicans isolates.
    Lee MK; Williams LE; Warnock DW; Arthington-Skaggs BA
    J Antimicrob Chemother; 2004 Feb; 53(2):217-24. PubMed ID: 14688046
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Molecular mechanism of azoles resistant Candida albicans in a patient with chronic mucocutaneous candidiasis.
    Zhang MR; Zhao F; Wang S; Lv S; Mou Y; Yao CL; Zhou Y; Li FQ
    BMC Infect Dis; 2020 Feb; 20(1):126. PubMed ID: 32046674
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Overexpression and mutation as a genetic mechanism of fluconazole resistance in Candida albicans isolated from human immunodeficiency virus patients in Indonesia.
    Rosana Y; Yasmon A; Lestari DC
    J Med Microbiol; 2015 Sep; 64(9):1046-1052. PubMed ID: 26297039
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Detection of ERG11 Overexpression in Candida albicans isolates from environmental sources and clinical isolates treated with inhibitory and subinhibitory concentrations of fluconazole.
    Morais Vasconcelos Oliveira J; Conceição Oliver J; Latércia Tranches Dias A; Barbosa Padovan AC; Siqueira Caixeta E; Caixeta Franco Ariosa M
    Mycoses; 2021 Feb; 64(2):220-227. PubMed ID: 33176021
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Changes in susceptibility to posaconazole in clinical isolates of Candida albicans.
    Li X; Brown N; Chau AS; López-Ribot JL; Ruesga MT; Quindos G; Mendrick CA; Hare RS; Loebenberg D; DiDomenico B; McNicholas PM
    J Antimicrob Chemother; 2004 Jan; 53(1):74-80. PubMed ID: 14657086
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Expression of Major Efflux Pumps in Fluconazole-Resistant Candida albicans.
    Pourakbari B; Teymuri M; Mahmoudi S; Valian SK; Movahedi Z; Eshaghi H; Mamishi S
    Infect Disord Drug Targets; 2017; 17(3):178-184. PubMed ID: 28558643
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 24.